EffiCacy and safety of ANagliptin when added to iNsulin and metformin therapy in patients with uncontrolled type 2 diAbetes; randomized, placebo-controlled, double-blind, multicentre trial (CANNA study)

Ji Eun Jun; Sung Hee Choi; Min Kyong Moon; Seung Hyun Ko; Hae Jin Kim; Kyu Yeoun Hur; Eun Jung Rhee; Jung Hyun Noh; In Kyung Jeong

doi:10.1111/dom.16557

EffiCacy and safety of ANagliptin when added to iNsulin and metformin therapy in patients with uncontrolled type 2 diAbetes; randomized, placebo-controlled, double-blind, multicentre trial (CANNA study)

Ji Eun Jun
, Sung Hee Choi
, Min Kyong Moon
, Seung Hyun Ko
, Hae Jin Kim
, Kyu Yeoun Hur
, Eun Jung Rhee
, Jung Hyun Noh
, In Kyung Jeong

Department of Internal Medicine

Kyung Hee University
Seoul National University
Seoul National University Boramae Medical Center
The Catholic University of Korea
Ajou University
Kangbuk Samsung Hospital
Inje University

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	5351-5355
Number of pages	5
Journal	Diabetes, Obesity and Metabolism
Volume	27
Issue number	9
DOIs	https://doi.org/10.1111/dom.16557
State	Published - Sep 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

DPP-IV inhibitor
antidiabetic drug
insulin resistance
randomized trial
type 2 diabetes

Access to Document

10.1111/dom.16557

Cite this

Jun, J. E., Choi, S. H., Moon, M. K., Ko, S. H., Kim, H. J., Hur, K. Y., Rhee, E. J., Noh, J. H., & Jeong, I. K. (2025). EffiCacy and safety of ANagliptin when added to iNsulin and metformin therapy in patients with uncontrolled type 2 diAbetes; randomized, placebo-controlled, double-blind, multicentre trial (CANNA study). Diabetes, Obesity and Metabolism, 27(9), 5351-5355. https://doi.org/10.1111/dom.16557

@article{ae124e7c704c427fb6854f14991389ed,

title = "EffiCacy and safety of ANagliptin when added to iNsulin and metformin therapy in patients with uncontrolled type 2 diAbetes; randomized, placebo-controlled, double-blind, multicentre trial (CANNA study)",

keywords = "DPP-IV inhibitor, antidiabetic drug, insulin resistance, randomized trial, type 2 diabetes",

author = "Jun, \{Ji Eun\} and Choi, \{Sung Hee\} and Moon, \{Min Kyong\} and Ko, \{Seung Hyun\} and Kim, \{Hae Jin\} and Hur, \{Kyu Yeoun\} and Rhee, \{Eun Jung\} and Noh, \{Jung Hyun\} and Jeong, \{In Kyung\}",

year = "2025",

month = sep,

doi = "10.1111/dom.16557",

language = "English",

volume = "27",

pages = "5351--5355",

journal = "Diabetes, Obesity and Metabolism",

issn = "1462-8902",

publisher = "John Wiley and Sons Inc",

number = "9",

}

Jun, JE, Choi, SH, Moon, MK, Ko, SH, Kim, HJ, Hur, KY , Rhee, EJ, Noh, JH & Jeong, IK 2025, 'EffiCacy and safety of ANagliptin when added to iNsulin and metformin therapy in patients with uncontrolled type 2 diAbetes; randomized, placebo-controlled, double-blind, multicentre trial (CANNA study)', Diabetes, Obesity and Metabolism, vol. 27, no. 9, pp. 5351-5355. https://doi.org/10.1111/dom.16557

EffiCacy and safety of ANagliptin when added to iNsulin and metformin therapy in patients with uncontrolled type 2 diAbetes; randomized, placebo-controlled, double-blind, multicentre trial (CANNA study). / Jun, Ji Eun; Choi, Sung Hee; Moon, Min Kyong et al.
In: Diabetes, Obesity and Metabolism, Vol. 27, No. 9, 09.2025, p. 5351-5355.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - EffiCacy and safety of ANagliptin when added to iNsulin and metformin therapy in patients with uncontrolled type 2 diAbetes; randomized, placebo-controlled, double-blind, multicentre trial (CANNA study)

AU - Jun, Ji Eun

AU - Choi, Sung Hee

AU - Moon, Min Kyong

AU - Ko, Seung Hyun

AU - Kim, Hae Jin

AU - Hur, Kyu Yeoun

AU - Rhee, Eun Jung

AU - Noh, Jung Hyun

AU - Jeong, In Kyung

PY - 2025/9

Y1 - 2025/9

KW - DPP-IV inhibitor

KW - antidiabetic drug

KW - insulin resistance

KW - randomized trial

KW - type 2 diabetes

UR - https://www.scopus.com/pages/publications/105008931037

U2 - 10.1111/dom.16557

DO - 10.1111/dom.16557

M3 - Letter

C2 - 40557734

AN - SCOPUS:105008931037

SN - 1462-8902

VL - 27

SP - 5351

EP - 5355

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

IS - 9

ER -

EffiCacy and safety of ANagliptin when added to iNsulin and metformin therapy in patients with uncontrolled type 2 diAbetes; randomized, placebo-controlled, double-blind, multicentre trial (CANNA study)

UN SDGs

Keywords

Access to Document

Other files and links

Cite this